Skip to main content

Comparison of the Anticoagulant Action of Recombinant Human Activated Protein C in Cord with that in Adult Plasma

  • Conference paper
34th Hemophilia Symposium

Conclusions

We found that under both high and low coagulant challenge clotting time was dosedependently prolonged, thrombin potential and prothrombin fragment 1+2 generation were dose-dependently suppressed in the presence of increasing amounts of rhAPC in both cord and adult plasma.Whereby, cord plasma was significantly more susceptible to addition of rhAPC in the presence of high amounts of TF as trigger for clot formation and adult plasma was significantly more susceptible to addition of rhAPC in the presence of low amounts of TF.Whereas the elevated anticoagulant action of rhAPC in cord plasma under high coagulant challenge might be caused by the low neonatal levels of prothrombin, we demonstrate that the increased anticoagulant efficacy of rhAPC in adult plasma under low coagulant challenge is attributable to the physiologically high levels of TFPI and AT present in adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut F, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.

    Article  PubMed  CAS  Google Scholar 

  2. Van’t Veer C, Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor-activated thrombin generation. J Biol Chem 1997; 272: 7983–94.

    Google Scholar 

  3. Cvirn G, Gallistl S, Rehak T, Jürgens G, Muntean W. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost 2003; 1: 1785–90.

    PubMed  CAS  Google Scholar 

  4. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165–72.

    PubMed  CAS  Google Scholar 

  5. Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63: 27–30.

    PubMed  CAS  Google Scholar 

  6. Rijkers DT, Wielders SJ, Beguin S, Hemker HC. Prevention of the influence of fibrin and alpha 2-macroglobulin in the continuous measurement of the thrombin potential: Implications for an endpoint determination of the optical density. Thromb Res 1998; 89: 161–9.

    Article  PubMed  CAS  Google Scholar 

  7. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617–24.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this paper

Cite this paper

Cvirn, G. et al. (2005). Comparison of the Anticoagulant Action of Recombinant Human Activated Protein C in Cord with that in Adult Plasma. In: Scharrer, I., Schramm, W. (eds) 34th Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27022-1_14

Download citation

  • DOI: https://doi.org/10.1007/3-540-27022-1_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22886-8

  • Online ISBN: 978-3-540-27022-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics